The first Brainstorm Cell Therapeutics trade was made in Q3 2017.
Since then Jim Simons bought shares fourteen more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -13.6k shares
Q4 2023
Avg closing price
$3.00
Price range
$2.22
-
$6.00
Sold 1.5% shares (-212 shares)
Q3 2023
Avg closing price
$22.47
Price range
$3.00
-
$31.20
New holding (+13.8k shares)
Q2 2023
Avg closing price
$41.44
Price range
$30.00
-
$48.00
Sold -786 shares
Q1 2023
Avg closing price
$29.01
Price range
$21.45
-
$49.50
Sold 78.8% shares (-2.93k shares)
Q4 2022
Avg closing price
$37.38
Price range
$20.55
-
$66.30
Increased shares by 225.7% (+2.57k shares)
Q3 2022